A vir­tu­al biotech in­cu­ba­tor is launch­ing with the help of Evotec and Sam­sara, look­ing for a few good sci­en­tists in need of seed cash for spin­outs

By any mea­sure, mon­ey has been pour­ing in­to the bio­phar­ma R&D field for more than 5 years now, with every stage of de­vel­op­ment crowd­ed with in­vestors look­ing for the next big thing in ther­a­peu­tics.

Val­ue in­flec­tion points are the guid­ing star of that multi­bil­lion-dol­lar busi­ness.

But a busy Sam­sara Bio­Cap­i­tal, the fam­i­ly fund KCK and the big Eu­ro­pean CRO Evotec are back­ing the play of a pair of in­vestors who have staked out a field where there doesn’t seem to be quite so much den­si­ty.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER